Opus Genetics, Inc.
IRDNasdaqCIK 1228627HealthcareFiscal year ends Dec 31
Reports and events: 307 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2116:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001140361-26-040377 |
| 2026-10-1517:23 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-039781 |
| 2026-09-1107:48 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-036277 |
| 2026-09-0907:30 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-035979 |
| 2026-08-0616:32 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001628280-26-054381 |
| 2026-08-0607:04 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-053824 |
| 2026-06-1616:11 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-025440 |
| 2026-06-1612:05 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-025363 |
| 2026-05-2019:53 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001193125-26-233062 |
| 2026-05-1216:03 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001628280-26-034084 |
| 2026-05-1207:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-033856 |
| 2026-04-2417:08 ET | 8-K | 2.03 New direct financial obligation | 0001140361-26-016764 |
| 2026-04-2206:02 ET | 8-K | 5.07 Shareholder vote results | 0001140361-26-015990 |
| 2026-04-0707:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001140361-26-013481 |
| 2026-04-0719:42 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-013394 |
| 2026-03-2316:06 ET | DEF 14A | Proxy statementPeriod 2026-04-20 | 0001140361-26-010757 |
| 2026-03-1216:52 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001140361-26-009247 |
| 2026-03-1007:17 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-26-008621 |
| 2026-02-1916:02 ET | 8-K | 1.01 Entry into a material agreement; 2.02 Results of operations; 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-006176 |
| 2026-01-1209:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-000913 |
| 2026-01-0807:10 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-000615 |
| 2025-12-1916:05 ET | 8-K | 8.01 Other events | 0001140361-25-046187 |
| 2025-12-1120:52 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001193125-25-316569 |
| 2025-11-1207:23 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001140361-25-041547 |
| 2025-11-1207:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-25-041544 |
| 2025-11-0616:31 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-040796 |
| 2025-11-0608:25 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-040675 |
| 2025-09-3007:24 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-036637 |
| 2025-09-0216:52 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-25-033668 |
| 2025-08-2517:19 ET | 8-K | 3.02 Unregistered sale of equity | 0001140361-25-032533 |
| 2025-08-1316:47 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001140361-25-030836 |
| 2025-08-1316:32 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-25-030822 |
| 2025-07-2308:15 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-25-026853 |
| 2025-06-2607:06 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-023732 |
| 2025-06-2516:22 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001140361-25-023648 |
| 2025-06-2308:34 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-25-023265 |
| 2025-06-2016:11 ET | 8-K | 1.01 Entry into a material agreement | 0001140361-25-023172 |
| 2025-05-1516:02 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001140361-25-019266 |
| 2025-05-1508:27 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-25-019153 |
| 2025-05-0617:55 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0000950170-25-064711 |
| 2025-05-0116:52 ET | 8-K | 5.07 Shareholder vote results | 0001140361-25-016948 |
| 2025-04-0416:39 ET | 8-K | 1.02 Termination of a material agreement | 0001140361-25-012366 |
| 2025-03-3117:14 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001140361-25-011410 |
| 2025-03-3108:26 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-25-011181 |
| 2025-03-2417:27 ET | 8-K | 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-25-010064 |
| 2025-03-2017:27 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001140361-25-009729 |
| 2025-03-2009:21 ET | 8-K | 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001999371-25-002866 |
| 2025-03-0416:53 ET | 8-K | 8.01 Other events | 0001140361-25-006961 |
| 2025-01-2416:34 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001140361-25-001899 |
| 2025-01-2317:20 ET | 8-K | 8.01 Other events | 0001140361-25-001819 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 27, 2026, 16:48 ET. Listed shows no prices and gives no investment advice.